Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02992743
Title Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
GSK Investigational Site Tampa Florida 33612 United States Details
GSK Investigational Site Ann Arbor Michigan 48109 United States Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site New York New York 10065 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field